---

Structured Approach to Thrombocytopenia

For the Hematology Consultant — A Reference-Based Comprehensive Framework

Sources: Goldman-Cecil Medicine (26e), Harrison's Principles (22e/2025), Robbins & Kumar Basic Pathology, Henry's Clinical Diagnosis & Management by Laboratory Methods, Washington Manual of Medical Therapeutics, Tintinalli's Emergency Medicine

---

Step 1: Confirm the Platelet Count is Real

• Occurs due to EDTA-dependent platelet agglutination (in vitro phenomenon)
• Seen as platelet clumping on peripheral smear
• Confirm with repeat CBC in citrate- or heparin-anticoagulated tubes
• Reported in 0.1-0.2% of all CBC samples; suspected when thrombocytopenia is incidental without any bleeding

Goldman-Cecil: "Before initiating an extensive workup, the peripheral blood smear should be examined for artifactual platelet clumping ('pseudothrombocytopenia')."

---

Step 2: Severity Assessment and Bleeding Risk

Robbins: "Only when platelet counts fall to 20,000 to 50,000 platelets/μL is there an increased risk of post-traumatic bleeding; spontaneous bleeding is unlikely until counts fall below 5,000/μL."

• Wet purpura (hemorrhagic blisters in oral mucosa)
• Retinal hemorrhages
• Neurological symptoms (intracranial hemorrhage)
• Mucosal bleeding unresponsive to local measures

---

Step 3: Three-Mechanism Framework

┌─────────────────────────────────────────────────────────────┐
│                  THROMBOCYTOPENIA                           │
├──────────────────┬──────────────────┬───────────────────────┤
│  DECREASED       │  INCREASED       │  SPLENIC              │
│  PRODUCTION      │  DESTRUCTION     │  SEQUESTRATION/       │
│                  │                  │  DISTRIBUTION         │
└──────────────────┴──────────────────┴───────────────────────┘

---

Step 4: Full Differential Diagnosis by Mechanism

A. DECREASED PLATELET PRODUCTION

1. Generalized Bone Marrow Failure

2. Selective Impairment of Megakaryopoiesis

3. Ineffective Megakaryopoiesis

---

B. INCREASED PLATELET DESTRUCTION

I. IMMUNE-MEDIATED

1. Primary Immune Thrombocytopenia (ITP)

• Isolated thrombocytopenia; no secondary cause identified
• Autoantibodies (anti-GPIIb/IIIa, anti-GPIb/IX) → platelet destruction by RES
• Also impairs platelet release from megakaryocytes
• Peripheral smear: large platelets, otherwise normal
• BM biopsy: megakaryocyte hyperplasia (not required for diagnosis routinely)
• Diagnosis of exclusion

Harrison's 22e: "ITP is characterized by mucocutaneous bleeding and a low, often very low, platelet count, with an otherwise normal peripheral blood smear."

2. Secondary ITP (Immune Thrombocytopenia with Identified Cause)

3. Drug-Induced Immune Thrombocytopenia (DIIT)

4. Heparin-Induced Thrombocytopenia (HIT) - HIGH YIELD

Washington Manual: UFH carries 0.1-5% risk; LMWH <0.1%; fondaparinux - very rare.

• Anti-PF4 antibodies triggered by adenoviral vector COVID-19 vaccines
• High D-dimer, thrombosis in unusual sites (cerebral venous sinus, portal, splanchnic veins)
• Fatal ~20%; treat with IVIgG + non-heparin anticoagulant (avoid heparin entirely)

5. Alloimmune Thrombocytopenias

---

II. NON-IMMUNE (CONSUMPTIVE / MICROANGIOPATHIC) THROMBOCYTOPENIA

Thrombotic Microangiopathy (TMA) - CRITICAL DISTINCTION

Robbins: "TTP is caused by deficiencies of ADAMTS13, a metalloprotease that prevents the accumulation of hyperactive very-high-molecular-weight multimers of vWF."

Other Non-Immune Consumptive Causes

---

C. SPLENIC SEQUESTRATION / DISTRIBUTION

• Spleen normally sequesters ~30% of platelets; massive splenomegaly can sequester up to 90%
• Mechanism is passive, not actively destructive - platelet survival is normal
• Bone marrow shows normal megakaryocytes

---

D. DILUTIONAL THROMBOCYTOPENIA

• Massive transfusion of packed red cells without platelet replacement
• Hemodilution: after large-volume resuscitation
• Rule: after transfusion of ~10 units of pRBC, platelet count falls to ~50% of baseline

---

E. INCREASED PLATELET DISTRIBUTION / MISCELLANEOUS

---

F. INHERITED / CONGENITAL THROMBOCYTOPENIAS (often misdiagnosed as ITP)

Henry's Lab Methods: "Many patients with inherited thrombocytopenias are initially recognized in adulthood. In the absence of family history, there is risk for misdiagnosis as immune thrombocytopenia and potential for unnecessary therapy with steroids or splenectomy."

---

Step 5: Diagnostic Approach - Stepwise Workup

Initial Assessment (All Cases)

• Duration of thrombocytopenia (lifelong vs. acute)
• Family history (inherited)
• Bleeding history: type (mucocutaneous = platelet; deep = coagulation)
• All medications (including OTC, supplements, heparin exposure)
• Recent infections, vaccinations (VITT)
• Pregnancy status
• Alcohol use
• Autoimmune symptoms (joints, rash, photosensitivity)
• Constitutional symptoms (fever, weight loss, night sweats - lymphoma/HLH)
• Liver disease risk factors

• Petechiae, ecchymoses, wet purpura, retinal hemorrhages
• Spleen size (sequestration)
• Lymphadenopathy (lymphoma, infections)
• Stigmata of liver disease
• Features of CTD (malar rash, arthritis)
• Dysmorphic features (congenital)

Mandatory Initial Labs

Targeted Second-Line Tests

When to Perform Bone Marrow Biopsy

• Unexplained thrombocytopenia with other cytopenias
• Abnormal WBC differential or blasts on smear
• Failure to respond to ITP treatment
• Clinical suspicion of marrow infiltration (lymphoma, leukemia, metastases)
• Suspected MDS (dysplastic features on smear, macrocytosis)
• Before splenectomy (to exclude marrow failure)
• Suspected HLH

---

Step 6: Diagnostic Algorithm by Clinical Context

Thrombocytopenia confirmed on repeat CBC / smear
│
├─ Schistocytes on smear?
│   └─ YES → TMA workup: TTP (ADAMTS13) / HUS / DIC / HELLP
│
├─ Heparin exposure?
│   └─ YES → 4T score → HIT workup
│
├─ Recent vaccine (adenoviral)?
│   └─ YES → Consider VITT (check D-dimer, anti-PF4 Ab)
│
├─ Other cytopenias (pancytopenia)?
│   └─ YES → Bone marrow biopsy (aplastic anemia, leukemia, MDS, myelofibrosis)
│
├─ Splenomegaly on exam/imaging?
│   └─ YES → Hypersplenism workup (portal HTN, lymphoma, storage disease)
│
├─ Drugs implicated?
│   └─ YES → Drug-induced thrombocytopenia; stop offending agent
│
├─ Pregnant?
│   └─ YES → Gestational thrombocytopenia vs. HELLP vs. ITP vs. TTP
│
├─ Positive HIV/HCV?
│   └─ YES → Treat infection; secondary ITP
│
├─ Family history / lifelong / refractory?
│   └─ YES → Inherited thrombocytopenia workup (platelet morphology, genetics)
│
└─ Isolated thrombocytopenia, none of the above?
    └─ ITP (diagnosis of exclusion after ruling out secondary causes)

---

Step 7: Special Situations

Thrombocytopenia in Pregnancy

Thrombocytopenia in ICU / Hospital Setting

• Most common causes: sepsis, DIC, drug-induced, HIT, dilutional
• Always review medication list
• Always check 4T score in any patient on heparin with falling platelets
• DIC is the most common cause of severe thrombocytopenia in ICU

Thrombocytopenia + Thrombosis (the paradox)

1. HIT (most common)
2. VITT
3. APS / Catastrophic APS
4. PNH
5. TTP (thrombotic microangiopathy)

---

Summary: Key Differentiating Features at a Glance

---

• Goldman-Cecil Medicine International Edition, Chapter 158 (Thrombocytopenia) and Chapter 359 (HIV)
• Harrison's Principles of Internal Medicine, 22e (2025), Chapter on Platelet Disorders
• Robbins & Kumar Basic Pathology, Table 10.11 (Causes of Thrombocytopenia)
• Henry's Clinical Diagnosis and Management by Laboratory Methods, Chapter 41 (Thrombocytopenia and Inherited Thrombocytopenias)
• Washington Manual of Medical Therapeutics (4T Scoring, HIT Management)
• Tintinalli's Emergency Medicine, Chapter 233 (Thrombocytopenia classification table)